Spots Global Cancer Trial Database for thoracic radiotherapy
Every month we try and update this database with for thoracic radiotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Use of Dual Energy Computed Tomography in Thoracic Radiotherapy Planning. | NCT04863027 | Lung Cancer Lung Function D... Radiation Pneum... | Thoracic radiot... | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy | NCT05552846 | Small-cell Lung... | thoracic radiot... | 18 Years - 80 Years | Ruijin Hospital | |
| Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | NCT02934503 | Small Cell Lung... | Pembrolizumab Cisplatin Carboplatin Etoposide Radiation thera... | 19 Years - | NYU Langone Health | |
| ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer | NCT00328562 | Non-Small Cell ... | ZD1839 (Iressa) Thoracic Radiot... | 18 Years - | Thomas Jefferson University | |
| Aggressive Thoracic Radiotherapy for Stage Ⅳ Non Small Cell Lung Cancer | NCT03565120 | Carcinoma, Non-... Stage IV Thoracic Radiot... | Aggressive Thor... | 18 Years - 80 Years | Jiangmen Central Hospital | |
| Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer | NCT01426841 | Small Cell Lung... | Adaptive Radiat... | 18 Years - | AHS Cancer Control Alberta | |
| Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer | NCT03923270 | Small Cell Lung... Small-cell Lung... | Durvalumab Tremelimumab Olaparib Pill Thoracic Radiot... Tremelimumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Addition of Radiotherapy to Standard Medical Treatment for Stage IV NSCLC | NCT04530708 | Radiotherapy Non Small Cell ... Stage IV Non-sm... Quality of Life | Thoracic radiot... | 18 Years - | Swedish Lung Cancer Study Group | |
| Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer | NCT05223647 | Small-cell Lung... | Thoracic radiot... Chemo-immunothe... | 18 Years - | Norwegian University of Science and Technology | |
| A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer | NCT01000480 | Non Small Cell ... | Pemetrexed Cisplatin Thoracic Radiot... | 18 Years - | Eli Lilly and Company | |
| Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC) | NCT01091376 | Non-small Cell ... | Erlotinib Thoracic radiot... | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung Cancer | NCT03673657 | Local Advanced ... | Early Nutrition... Thoracic radiot... Weekly DP chemo... | 18 Years - 75 Years | Sun Yat-sen University | |
| Optimization of Radiation Protection Through Genomic Analyses | NCT06253338 | DNA Cancer Radiation | genomic alterat... | 18 Years - | University Hospital, Essen | |
| Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer | NCT02375581 | Esophageal Canc... | Icotinib Thoracic radiot... | 70 Years - 85 Years | First People's Hospital of Hangzhou | |
| PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients | NCT05651802 | Small Cell Lung... | Prophylactic cr... Thoracic radiot... Chemotherapy | 18 Years - | Zhejiang Cancer Hospital | |
| Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy | NCT06187740 | Small Cell Lung... | thoracic radiot... | 18 Years - | Fudan University | |
| Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy | NCT05796089 | Extensive-Stage... | Thoracic Radiot... Etoposide with ... Durvalumab | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer | NCT02675088 | Carcinoma, Smal... Lung Neoplasms | high-dose TRT standard-dose T... | 18 Years - 70 Years | ChineseAMS | |
| Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC | NCT02353741 | Non Small Cell ... | EGFR-TKIs thoracic radiot... | 18 Years - 75 Years | Xinqiao Hospital of Chongqing | |
| Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer | NCT02375581 | Esophageal Canc... | Icotinib Thoracic radiot... | 70 Years - 85 Years | First People's Hospital of Hangzhou | |
| Thoracic RadiothErapy With Atezolizumab in Small Cell lUng canceR Extensive Disease | NCT04462276 | Small Cell Lung... Thoracic Radiot... | Atezolizumab thoracic radiot... | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | NCT04472949 | Small Cell Lung... Lung Cancer | Durvalumab carboplatin etoposide Thoracic radiot... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Talazoparib and Thoracic RT for ES-SCLC | NCT04170946 | Lung Cancer Small-Cell Lung... | Talazoparib in ... | 18 Years - | University Health Network, Toronto | |
| Chemotherapy and Immunotherapy in Extensive-Stage Small-Cell Lung Cancer With Thoracic Radiotherapy | NCT05796089 | Extensive-Stage... | Thoracic Radiot... Etoposide with ... Durvalumab | 18 Years - | Trans Tasman Radiation Oncology Group | |
| Safety Study of Bevacizumab (Avastin) With Thoracic Radiation in Non-small Cell Cell Lung Cancer | NCT00531076 | Toxicity | bevacizumab | - | Amsterdam UMC, location VUmc | |
| Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer | NCT01426841 | Small Cell Lung... | Adaptive Radiat... | 18 Years - | AHS Cancer Control Alberta | |
| Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC | NCT02353741 | Non Small Cell ... | EGFR-TKIs thoracic radiot... | 18 Years - 75 Years | Xinqiao Hospital of Chongqing | |
| Optimization of Radiation Protection Through Genomic Analyses | NCT06253338 | DNA Cancer Radiation | genomic alterat... | 18 Years - | University Hospital, Essen | |
| Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial | NCT05403736 | Cancer | Cardiac Aggress... | 18 Years - | Cedars-Sinai Medical Center | |
| Radiation and Chemotherapy With Ipilimumab Followed by Nivolumab for Patients With Stage III Unresectable Non-Small Cell Lung Cancer (NSCLC) | NCT03663166 | Carcinoma, Non-... | Thoracic Radiot... Platinum Based ... ipilimumab Nivolumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). | NCT04472949 | Small Cell Lung... Lung Cancer | Durvalumab carboplatin etoposide Thoracic radiot... | 18 Years - | Swiss Group for Clinical Cancer Research | |
| A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma | NCT06354530 | Neoadjuvant The... Esophageal Squa... | anlotinib Thoracic radiot... | 18 Years - 80 Years | Army Medical Center of PLA | |
| Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy | NCT06187740 | Small Cell Lung... | thoracic radiot... | 18 Years - | Fudan University | |
| Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy | NCT05552846 | Small-cell Lung... | thoracic radiot... | 18 Years - 80 Years | Ruijin Hospital | |
| Aggressive Thoracic Radiotherapy for Stage Ⅳ Non Small Cell Lung Cancer | NCT03565120 | Carcinoma, Non-... Stage IV Thoracic Radiot... | Aggressive Thor... | 18 Years - 80 Years | Jiangmen Central Hospital | |
| Temozolomide as Maintenance Therapy Following Induction Chemotherapy in Extensive Stage Small Cell Lung Cancer | NCT02772107 | Extensive-stage... | Temozolomide first-line chem... Prophylactic cr... thoracic radiot... | 18 Years - 75 Years | Chinese PLA General Hospital | |
| MEK Inhibitor and Thoracic Radiotherapy Trial | NCT01146756 | Non Small Cell ... | AZD6244 | 18 Years - | The Christie NHS Foundation Trust | |
| Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapy | NCT06187740 | Small Cell Lung... | thoracic radiot... | 18 Years - | Fudan University | |
| Radiotherapy and Durvalumab/Durvalumab Combo (Tremelimumab/Olaparid) for Small Cell Lung Cancer | NCT03923270 | Small Cell Lung... Small-cell Lung... | Durvalumab Tremelimumab Olaparib Pill Thoracic Radiot... Tremelimumab | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) | NCT04380636 | Lung Neoplasms Carcinoma, Non-... | Pembrolizumab Olaparib Placebo for ola... Etoposide Carboplatin Cisplatin Paclitaxel Pemetrexed Thoracic Radiot... Durvalumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Study of Pembrolizumab and Chemotherapy With or Without Radiation in Small Cell Lung Cancer (SCLC) | NCT02934503 | Small Cell Lung... | Pembrolizumab Cisplatin Carboplatin Etoposide Radiation thera... | 19 Years - | NYU Langone Health | |
| Optimization of Radiation Protection Through Genomic Analyses | NCT06253338 | DNA Cancer Radiation | genomic alterat... | 18 Years - | University Hospital, Essen | |
| Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) | NCT04380636 | Lung Neoplasms Carcinoma, Non-... | Pembrolizumab Olaparib Placebo for ola... Etoposide Carboplatin Cisplatin Paclitaxel Pemetrexed Thoracic Radiot... Durvalumab | 18 Years - | Merck Sharp & Dohme LLC | |
| Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy | NCT04351256 | NSCLC, Stage II... | Durvalumab Inje... Thoracic Radiot... Thoracic Radiot... | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Cardiac Aggressive Risk Mitigation in Thoracic Radiotherapy (CARMA) Trial | NCT05403736 | Cancer | Cardiac Aggress... | 18 Years - | Cedars-Sinai Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
